Endoglin is a component of the transforming growth factor (TGF)-β receptor complex of human pre-B leukemic cells

Journal of Immunology

Volumn 156, Issue 2, 1996, Pages 565-573

  Zhang, Hongwei ^a,b   Shaw, Andrew R E ^c   Mak, Allan ^c   Letarte, Michelle ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; ENDOGLIN; FIBRONECTIN; GLYCAN; INTEGRIN; MESSENGER RNA; TETRAZOLIUM; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; ACTIVIN RECEPTOR 1; BETAGLYCAN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROTEIN SERINE THREONINE KINASE; PROTEOGLYCAN; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; TUMOR PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; B CELL LEUKEMIA; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMOBILIZED CELL; LEUKEMIA CELL; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CELL MOTION; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MACROMOLECULE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS, TYPE I; ANTIGENS, CD; BASE SEQUENCE; CELL DIVISION; CELL MOVEMENT; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, PRE-B-CELL; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030071563     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Quackenbush, E. J., and M. Letarte 1985. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J. Immunol. 134:1276.
2. Gougos, A , and M. Letarte 1988. Biochemical characterization of the 44G4 antigen from the HOON pre-B leukemic cell line. J. Immunol. 141:1934.
3. Gougos, A., and M. Letarte. 1988 Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J. Immunol. 141:1925.
4. Letarte, M , A. Greaves, and S. Vera 1995. CD105 (Endoglin) Cluster Report In Leukocyte Typing v White Cell Differentiation Antigens. S. F Schlossman, L. Boumsell, W. Gilks, J. Harlan, T. Kishimoto, C Morimoto, J Ritz, S. Shaw, R Silverstein, T Springer, T. Tedder, and R. Todd, eds Oxford University Press, Oxford, pp. 1756-1759
5. McAllisler, K. A , K M. Grogg, D. W. Johnson, C. J Gallione, M A Baldwin, C. E Jackson, E. A Helmbold, D S Markel, W. C. McKinnon, J Murrell, M K. McCormick, M A Pericak-Vance, P. Heutink, B. A. Oostra, T. Haitjema, C J J Westerman, M. E. Porteus, A. E. Guttmacher, M. Letarte, and D. A. Marchuk. 1994. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat. Genet. 8:345
6. López-Casillas, F., S. Cheifetz, J. Doody, J. L Andres, W. S. Lane, and J. Massagué. 1991. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor Cell 67 785.
7. Wang, X.-F., H. Y Lin, E. Ng-Eaton, J. Downward, H. F Lodish, and R A Weinberg. 1991. Expression cloning and characterization of the TGF-β type III receptor Cell 67:797
8. Gougos, A., and M. Letarte 1990 Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem 265:8361.
9. Cheifetz, S., T. Bellón, C. Calés, S. Vera, C. Bernabeu, J. Massagué, and M Letarte. 1992. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells J. Biol Chem 267:19027.
10. Bellón, T., A. Corbi, P. Lastres, C Calés, M. Cebrián, S. Vera, M. Chefeitz, J. Massagué, M. Letarte, and C. Bernabeu. 1993. Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic regions. Eur. J. Immunol 23.2340.
11. St.-Jacques, S., U. Cymerman, N Pece, and M. Letarte. 1994. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-β binding protein of endothelial and stromal cells. Endocrinology 134:2645
12. Cheifetz, S., J L. Andres, and J. Massagué 1988. The transforming growth factor-β receptor type III is a membrane proteoglycan. J Biol. Chem 32:16984
13. Andres, J. L , K. Stanley, S. Cheifetz, and J. Massagué. 1989. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β J Cell Biol 109:3137.
14. López-Casillas, F , J. L Wrana, and J. Massagué. 1993. Betaglycan presents ligand to the TGF-β signaling receptor. Cell 73:1435.
15. Yamashita, H , H. Ichijo, S Grimsby, A. Morén, P. ten Dijke, and K. Miyazono 1994 Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β J Biol Chem. 269:1995.
16. Lin, H. Y , X.-F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F. Lodish. 1992. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68 775.
17. Franzén, P., P. ten Dijke, H. Ichijo, H Yamashita, P Schulz, C.-H. Heldin, and K. Miyazono 1993. Cloning of the TGFβ type 1 receptor that forms a heteromeric complex with the TGFβ type II receptor Cell 75:681.
18. Wrana, J. L., L Attisano, J. Cárcamo, A. Zentella, J. Doody, M. Laiho, X-F Wang, and J. Massagué. 1992. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71:1003.
19. Wrana, J. L., L Attisano, R Wieser, F Ventura, and J. Massagué. 1994. Mechanisms of activation of the TGF-β receptor. Nature 370:341.
20. Miyazono, K., P. ten Dijke, H Ichijo, and C -H Heldin 1994. Receptors for transforming growth factor-β Adv Immunol 55:181
21. Massagué, J., L. Attisano, and J. L Wrana. 1994. The TGF-β family and its composite receptors. Trends Cell Biol 4:172.
22. Kimchi, A., X.-F. Wang, R. A. Weinberg, S. Cheifetz, and J. Massagué. 1988. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells Science 240:196.
23. Cheifetz, S , H. Hernandez, M. Laiho, P. ten Dijke, K. K. Iwata, and J. Massagué. 1990 Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J. Biol. Chem. 265: 20533.
24. Ohta, M., J. S. Greenberger, P. Anklesaria, A. Bassols, and J. Massagué. 1987 Two forms of transforming growth factor-β distinguished by multipotential haemopoietic progenitor cells Nature 329:539.
25. Lastres, P., T. Bellon, C. Cabanas, F. Sanchez-Madrid, A. Acevedo, A. Gougos, M Letarte, and C. Bernabeu. 1992 Regulated expression on human macrophages of endoglin, an RGD containing surface antigen. Eur. J Immunol. 22:393.
26. O'Connell, P. J., A. McKenzie, N. Fisicaro, S. P Rockman, M. J. Pearse, and A. J. F. d'Apice. 1992. Endoglin: a 180-kD endothelial and macrophage-restricted differentiation molecule. Clin Exp Immunol. 90:154.
27. Buhring, H -J., C. A. Muller, M. Letarte, A. Gougos, A. Saalmuller, A J. van Agthoven, and F W. Busch 1991. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow. Leukemia 5:841
28. Rokhlin, O. W., M B. Cohen, H Kubagawa, M. Letarte, and M D. Cooper. 1995 Differential expression of endoglin in fetal and adult hematopoietic cells in human bone marrow. J. Immunol. 154:4456.
29. Kreindler, D., D Petsche, A Hrincu, A. Gougos, E. J. Quackenbush, M. H. Freedman, E W. Gelfand, and M Letarte. 1990. Quantitative phenotyping of childhood leukemia identifies variable and invariable cell surface antigens. Leuk. Lymphoma 3:7.
30. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S Jakowlew, M. Alvarez-Mon, R. Derynck, M B. Sporn, and A. S Fauci. 1986 Production of Transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth J Exp. Med 163.1037.
31. Kehrl, J. H., A. S. Taylor, G A. Delsing, A. B. Roberts, M B. Sporn, and A. S. Fauci. 1989. Further studies of the role of transforming growth factor-β in human B cell function J Immunol 143:1868.
32. Kehrl, J. H., A. Taylor, S -J. Kim, and A. S. Fauci. 1991. Transforming growth factor-β is a potent negative regulator of human lymphocytes Ann NY Acad. Sci. 628:345.
33. Ruscetti, F W., S. E. Jacobsen, M Birchenall-Roberts, H E. Broxmeyer, G L. Engelmann, C Dubois, and J. R. Keller. 1991 Role of transforming growth factor-β1 in regulation of hematopoiesis. Ann. NY Acad Sci. 628:31.
34. Keller, J R., S. E W Jacobsen, C M Dubois, K. Hestdal, and F. W. Ruscetti. 1992 Transforming growth factor-β: a bidirectional regulator of hematopoietic cell growth. Int. J. Cell Cloning 10.2
35. Hestdal, K , S. E. W. Jacobsen, F. W Ruscetti, D L. Longo, T. C. Boone, and J R Keller. 1993. Increased granulopoiesis after sequential administration of transforming growth factor-β1 and granulocyte-macrophage colony-stimulating factor. Exp. Hematol 21 799
36. Piacibello, W , A. Severino, A. Stacchini, and M Aglietta 1991 Differential effect of transforming growth factor β1 on the proliferation of human lymphoid and myeloid leukemia cells. Haematologica 76:460.
37. Rehmann, J. A., and T. W. LeBien. 1994 Transforming growth factor-β regulates normal human pre-B cell differentiation. J. Immunol. 6.315
38. Okamura, J., H. Okano, Y. Ikuno, H. Tasaka, S. Motomura, M. Letarte, and E. W. Gelfand 1984. Characterization of new non-T, non-B acute lymphoblastic leukemia cell lines Analysis of surface antigens by quantitative cellular radioimmunoassay and flow cytometry Leuk. Res. 8:97.
39. Hurwitz, R., J Hozier, J. Minowada, K. Gajl-Peczalska, I. Kubonishi, and J. Kersey. 1979 Characterizaton of a leukemic cell line of the pre-B phenotype Int. J. Cancer 23:174.
40. Kamel-Reid, S., J. E. Dick, A. Greaves, B. Murdoch, M Doedens, T Grunberger, P. Thorner, M H. Freedman, R. A. Phillips, and M. Letarte. 1992. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice. Leukemia 6:8
41. Letarte, M , J. G Seehafer, A. Greaves, A Masellis-Smith, and A R E. Shaw. 1993 Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9. Leukemia 7:93.
42. Scudiero, D A , R H. Shoemaker, K. D Paull, A Monks, S. Tierney, T. H. Nofziger, M J. Currens, D Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48.4827.
43. Massagué, J. 1987. Identification of receptors for type-β transforming growth factor. Methods Enzymol. 146:174
44. Chomczynski, P . and N. Sacchi 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
45. Jindal, S K., E. Ishii, M. Letarte, S Vera, K. J. Teerds, and J. H. Dorrington. 1995 Regulation of TGFα gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biol Reprod. 52:1027.
46. Derynck, R , J. A. Jarrett, E. Y. Chen, D. H Eaton, J. R. Bell, R. K. Assoian, A B. Roberts, M B. Sporn, and D. V Goeddel. 1985. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316.701
47. Feinmesser, R., I. Miyazaki, R. Cheung, J. L. Freeman, A M. Noyek, and H. Dosch. 1992. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N. Engl. J. Med. 326:17.
48. Nakajima-Iijima, S., H. Hamada, P. Reddy, and T. Kakunaga 1985. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc. Nat. Acad. Sci. USA 82:6133.
49. Moren, A., H. Ichijo, and K. Miyazono. 1992. Molecular cloning and characterization of the human and porcine transforming growth factor-β type III receptors. Biochem. Biophys Res. Commun. 189.356.
50. Murphy, L. D., C. E Herzog, J B Rudick, A. T. Fojo, and S. E. Bates 1990. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 29:10351.
51. Ishii, E., A Greaves, T. Grunberger, M H Freedman, and M. Letarte. 1993. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice. Leukemia 7:1592.
52. Ishii, E , A Greaves, T. Grunberger, M H. Freedman, and M. Letarte. 1995. Tumor formation by a human pre-B leukemia cell line in Scid mice is enhanced by Matrigel and is associated with induction of CD10 expression. Leukemia 9:175.
53. Kadin, M. E., M W. Cavaille-Coll, R Gertz, J. Massagué, S. Chefeitz, and D. George. 1994 Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc. Natl. Acad. Sci. USA 91.6002.
54. Uckun, F. M., C. Manivel, D. Arthur, L M Chelstrom, D Finnegan, L. Tuel-Ahlgren, J. D. Irvin, D E Myers, and R. Gunther. 1992. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 79 2201
55. Lucas, C., L. N. Bald, B. M. Fendly, M. Mora-Worms, I. S. Figari, E. J. Patzer, and M. A. Palladino. 1990 The autocrine production of transforming growth factor-β1 during lymphocyte activation J. Immunol. 145:1415
56. Haines, K. A., S. L. Kolasinki, B N Cronstein, J. Reibman, L. I. Gold, and G. Weissman. 1993. Chemoattraction of neutrophils by substance P and transforming growth factor-β1 is inadequately explained by current models of lipid remodeling. J. Immunol 151:1491.
57. Mooradian, D. L., J. B. McCarthy, K V. Komanduri, and L T. Furcht. 1992. Effects of transforming growth factor-β1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J. Natl. Cancer Inst. 84:523.
58. Samuel, S. K., R. A R. Hurta, M. A. Spearman, J A. Wright, E. A. Turley, and A H Greenberg. 1993. TGF-β1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan J. Cell Biol. 123-749.
59. Brandes, M. E., L M Wakefield, and S. M. Wahl 1994. Modulation of monocyte type 1 transforming growth factor-β receptors by inflammatory stimuli. J. Biol. Chem. 266:19697.
60. Kincade, P. W., G. Lee, C. E Pietrangeli, S -I Hayashi, and J M. Gimble. 1989 Cells and molecules that regulate B lymphopoiesis in bone marrow. Annu. Rev. Immunol. 7:111.
61. Osmond, D. G., N. Kim, R Manoukian, R. A Phillips, S A. Rico-Vargas, and K Jacobsen. 1992 Dynamics and localization of early B-lymphocyte precursor cells (pro-B cells) in the bone marrow of scid mice Blood 79:1695.
62. Lord, B I 1990. The architecture of bone marrow cell populations Int. J. Cloning 8:317.
63. Miyake, K , Y. Hasunuma, H. Yagita, and M. Kimoto 1992. Requirement of VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture J. Cell Biol. 119:653
64. Tang, J., G Scott, and D H. Ryan. 1993. Subpopulations of bone marrow fibroblasts support VLA-4 mediated migration of B cell precursors. Blood 82:3415.
65. Huss, R., D.-S. Hong, C. Beckham, L Kimball, D H Myerson, R. Storb, and H. J. Deeg. 1995 Ultrastructural localization of stem cell factor in canine marrow-derived stromal cells. Exp. Hematol 23:33.
66. Kadouri, A., R Kompier, J. Honigwachs-Scha'anani, J Toledo, N. Brosh, D Sternberg, A. Levy, E. Tzehoval, and D Zipon. 1992 Dynamic changes in cytokine secretion by stromal cells during prolonged maintenance under protein-free conditions. Int J. Cell Cloning 10:299.
67. Dittel, B. N , J. B. McCarthy, E A. Wayner, and T W. Lebien. 1993. Regulation of human B cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1) Blood 81 2272.
68. Postlethwaite, A. E , J. Keski-Oja, H. L Moses, and A. H. Kang 1987. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp. Med. 165:251.
69. Reibman, J., S. Meixler, T. C Lee, L I. Gold, B. N. Cronstein, K. A. Haines, S. L. Kolansinki, and G. Weissmann. 1991. Transforming growth factor β1, a potent chemoattractant for human neutrophils, bypasses classical signal-transduction pathways. Proc Natl. Acad. Sci USA 88:6805.
70. Maghazachi, A. A., and A al-Aoukaty. 1993. Transforming growth factor-beta 1 is chemotactic for interleukin-1 activated natural killer cells Nat Immun. 12:57.